MATERNAL DOLUTEGRAVIR (DTG) USE, AND PREGNANCY AND BIRTH OUTCOMES: THE ANTIRETROVIRAL PREGNANCY REGISTRY (APR)

Press/Media

Period	30 Sep 2021

Media coverage

Title	MATERNAL DOLUTEGRAVIR (DTG) USE, AND PREGNANCY AND BIRTH OUTCOMES: THE ANTIRETROVIRAL PREGNANCY REGISTRY (APR)
Media name/outlet	National AIDS Treatment Advocacy Project
Country/Territory	United States
Date	30/09/21
URL	https://www.natap.org/2021/IDWeek/IDWeek_10.htm
Persons	Karen Beckerman